B. Braun Becomes First to Deliver FDA-Approved 2-g Cefazolin
B. Braun Medical Inc. recently announced it received US FDA approval for 2-g Cefazolin for Injection USP and Dextrose Injection USP in B. Braun’s DUPLEX Drug Delivery System. The FDA approval makes B. Braun the first company to deliver an FDA-approved 2-g Cefazolin dose to hospitals and other healthcare settings, where it is a frequently prescribed antibiotic.
The arrival of 2-g Cefazolin is welcome news. Until now, Cefazolin had only been available in 1-g IV and multi-dose vials. The 2-g Cefazolin in the DUPLEX system can be stored, ready to use wherever and whenever it is needed, which means faster, safer, and more accurate administration of 2-g Cefazolin to patients.
“B. Braun heard physician and pharmacist calls for a 2-g Cefazolin dose, and we’ve responded,” said Rob Albert, Vice President, Pharma Marketing for B. Braun. “2-g Cefazolin will be the latest in an expanding DUPLEX portfolio, which is designed to provide fast, safe, convenient, and Joint Commission and USP Chapter <797> compliant products that improve the practice of healthcare professionals while advancing patient safety and outcomes.”
B. Braun will offer 2-g Cefazolin delivered via its DUPLEX Delivery System, a ready-to-use two-compartment flexible plastic IV container that stores pre-measured drug and diluent doses. Healthcare workers administering DUPLEX simply squeeze the container and shake it to mix pharmaceuticals and diluent.
The DUPLEX system saves time, labor, and speeds dispensing because it can be stored right in emergency and operating rooms until it’s needed and is ready immediately. The DUPLEX container is not manufactured with latex, PVC, or DEHP. A barcode that references the final admixture, lot number, and expiration date helps reduce medication errors, automate patient charting, track inventory, and facilitate reimbursement tracking.
With the addition of 2-g Cefazolin to its drug delivery portfolio, B. Braun will expand its broad spectrum of intravenous cephalosporin antibiotic therapies for the hospital setting: Cefepime, Ceftazidime, Cefoxitin, CefTRIaxONE, Cefazolin, CefUROXime, and Cefotetan.
Total Page Views: 1198
